News and publishing service for hemp related companies
Contact us:
303.498.7722
twitter
facebook
linkedin
News and publishing service for hemp related companies
Home
About
Clients
Events
NewsRoom
Solutions
Contact
HW Headlines
2023 Maine Cannabis Convention Joins MMCM’s HomeGrown TradeShow for Nation-leading Event
NECANN’s New York Cannabis & Hemp Convention Set to Empower the Cannabis Industry
Lexaria Bioscience Corp. (LEXX) Steadily Advancing its DehydraTECH(TM) Technology
BizCann Expo: An Elite Business & Networking Event for All Things Cannabis
Alternative Products Expo: Innovation and Sustainability
HempNewsBreaks
HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Nicotine Pouch Demonstrates Advantages over Competition
Lexaria Bioscience Corp. (LEXX)
October 2, 2023
HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) New Subsidiary Maximizing Patented DehydraTECH(TM) in Various Markets
Lexaria Bioscience Corp. (LEXX)
September 15, 2023
HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets
Lexaria Bioscience Corp. (LEXX)
September 8, 2023
HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes Launching IND Program on DehydraTECH-CBD for Hypertension
Lexaria Bioscience Corp. (LEXX)
August 23, 2023
HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Study Reveals ‘Most Convincing Evidence’ of CBD’s Anti-Inflammatory Actions in Humans
Lexaria Bioscience Corp. (LEXX)
July 14, 2023
View More HempNewsBreaks
HempWire Articles
Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Advancing its DehydraTECH(TM) Technology, Having Demonstrated its Potential Across Multiple Areas of Application
Lexaria Bioscience Corp. (LEXX)
September 29, 2023
Lexaria Bioscience Corp. (NASDAQ: LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming Investigational New Drug Application Submission
Lexaria Bioscience Corp. (LEXX)
September 21, 2023
Lexaria Bioscience Corp. (NASDAQ: LEXX) is On Track for IND Application with the FDA for its Planned U.S. Phase 1b Hypertension Clinical Trial
Lexaria Bioscience Corp. (LEXX)
September 15, 2023
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Investigational Research Programs Position the Company for Important Partnership Opportunities and Growth
Lexaria Bioscience Corp. (LEXX)
September 12, 2023
NECANN’s New York Cannabis & Hemp Convention Set to Empower the Cannabis Industry
NECANN
September 5, 2023
View All HempWire Articles
HempNewsAudio
HempNewsAudio – Sugarmade, Inc. (SGMD) Exploring the New Generation of Hemp Processing Technology
Sugarmade, Inc. (SGMD)
June 28, 2019
HempNewsAudio – TransCanna Holdings Inc. (CSE: TCAN) Flourishing in the Evolving Cannabis Sector through Key Acquisitions
TransCanna Holdings Inc. (TCAN)
June 21, 2019
HempNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Attains Rapid Growth in the Mounting Cannabis Sector
Wildflower Brands Inc. (WLDFF)
June 20, 2019
HempNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advancing the Effective Delivery of Cannabinoids
Lexaria Bioscience Corp. (LXRP)
June 13, 2019
HempNewsAudio – Sugarmade, Inc. (SGMD) Expanding Product Offerings to Include Extraction Equipment
Sugarmade, Inc. (SGMD)
June 13, 2019
View All HempNewsAudio
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Medical Marijuana
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
HempWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
303.498.7722